CTOs on the Move

MSI

www.methylationsciences.com

 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

Spring Arbor Of Durham

Spring Arbor Of Durham is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

medic1

medic1 is a Baldwin Park, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Steri-Source

Steri-Source is a Burley, ID-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Thirty Madison

Thirty Madison exists to deliver on healthcare`s biggest opportunities: access and affordability; patient outcomes; and patient experience. With empathy at the heart of its innovation, its proprietary care model empowers hundreds of thousands of people with ongoing conditions with accessible, effective treatments across a lifetime of care.

PCA Services

PCA Services Inc. is a Oakville, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.